Prognostic variables and calcitonin in medullary thyroid cancer

Laryngoscope

Volumn 115, Issue 8, 2005, Pages 1445-1450

  Clark, Jonathan R ^a   Fridman, Tauba R ^a   Odell, Michael J ^a   Brierley, James ^b   Walfish, Paul G ^a   Freeman, Jeremy L ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Calcitonin; Distant metastases; Medullary thyroid cancer; Prognostic variables

Indexed keywords

(3 IODOBENZYL)GUANIDINE; ANTINEOPLASTIC AGENT; CALCITONIN; CARCINOEMBRYONIC ANTIGEN; CATECHOLAMINE; DOXORUBICIN; OCTREOTIDE; TAMOXIFEN;

ADULT; BONE METASTASIS; BONE SCINTISCANNING; BRAIN METASTASIS; CALCITONIN BLOOD LEVEL; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; THYROID CANCER; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CALCITONIN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, MEDULLARY; CHILD; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SURVIVAL ANALYSIS; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 23344441224     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000168114.90852.a6     Document Type: Review

References (15)

1. Modigliani E, Cohen R, Campos JM, et al. Prognostic factors for survival and for biochemicalcure in medullary thyroid carcinoma: results in 899 patients-The GETC Study Group (Groupe d'etude des tumeurs a calcitonine). Clin Endocrinol 1998;48:265-273.
2. Saad MF, Ordonez NG, Rashid RK. et al. Medullary carcinoma of the thyroid: a study of the clinical features and prognostic factors in 161 patients. Medicine 1984;63:319-342.
3. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma: a population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program, 1973-1991. Cancer 1997;79:564-573.
4. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985-1995. Cancer 1998;83:2638-2648.
5. Clayman GL, el-Baradie TS. Medullary thyroid cancer. Otolaryngol Clin North Am 2003;36:91-105.
6. Raue F, Kotzerke J, Reinwein D, et al. Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register. Clin Invest 1993;71:7-12.
7. Dottorini ME, Assi A, Sironi M, et al. Multivariate analysis of patients with medullary thyroid carcinoma: prognostic significance and impact on treatment of clinical and pathologic variables. Cancer 1996;77:1556-1565.
8. Gharib H, McConahey WM, Tiegs RD, et al. Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970. Mayo Clin Proc 1992;67:934-940.
9. Wells SA, Dilley WG, Farndon JA, et al. Early diagnosis and treatment of medullary thyroid carcinoma. Arch Intern Med 1985;145:1248-1252.
10. Randolph GW, Maniar D. Medullary carcinoma of the thyroid. Cancer Control 2000;7:253-261.
11. Sizemore GW, Heath III H, Carney JA. Multiple endocrine neoplasia type II. Clin Endocrinol Metab 1980;9:299-315.
12. Brierley J, Tsang R, Simpson, WJ, et al. Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control. Thyroid 1996;6:305-310.
13. Dottorini ME, Assi A, Sironi M, et al. Multivariate analysis of patients with medullary thyroid carcinoma. Cancer 1995; 77:1556-1565.
14. Hyer SL, Vini L, A'Hern R, Harmer C. Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival. Eur J Surg Oncol 2000;26:686-690.
15. Saad MF, Fritsche HA, Samaan NA. Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid. J Clin Endocrinol Metab 1984;58:889-894.